AI assistant
METabolic EXplorer — Earnings Release 2012
May 10, 2012
1519_iss_2012-05-10_b7f9d1fa-4a03-406c-a405-3e86e3421724.pdf
Earnings Release
Open in viewerOpens in your device viewer
METabolic Explorer reports turnover of €1.35 million for first quarter 2012
Clermont-Ferrand, 10 May 2012 – METabolic EXplorer, a green chemistry company that specializes in the development of bioprocesses for the production of chemical compounds used in a wide range of everyday products (textile fibres, paints, solvents, animal feed supplements, adhesives, etc.), today published its financial data for the first quarter of 2012.
Turnover for the period was €1.35 million, resulting from the industrial partnership with Roquette Frères on the L-Methionine project.
| Turnover (IFRS) – in €'000 | 2011 | 2012 |
|---|---|---|
| 1st quarter | 0 | 1,350 |
| Annual turnover | 850 |
At this stage of METabolic Explorer's development, this turnover figure is in no way a relevant metric of its value or business. METabolic EXplorer also stresses that the potential worldwide market for methionine is worth €2.85 billion or 850,000 metric tons*.
At 31 March 2012, METabolic EXplorer had €23.3 million in gross cash and equivalents.
*Source: FeedInfo, average price 2007-2011, spot lots of 50 metric tons.
-END-
About METabolic EXplorer - www.metabolic-explorer.com
METabolic EXplorer is a biological chemistry company. Incorporated in 1999 it aims to help industrial firms cope with the forthcoming end of the oil age so that they can continue manufacturing but in a sustainable way.
Based on the tried and tested principle of industrial fermentation, METabolic EXplorer's solutions circumvent the problems posed by today's burdensome and expensive petrochemical processes via the use of a wide range of renewable, sustainable raw materials. By optimizing the metabolic yield of non-pathogenic bacteria in a contained, controlled environment, the company facilitates the production of chemical compounds used in a wide range of everyday goods (textile fibres, paints, solvents, plastics and animal feed).
METabolic EXplorer is currently focusing its alternative biological solutions on the production of five compounds that together have an estimated, annual, end-market value of €11 billion. The company's strategy will be implemented in two forms – either via own-account developments (i.e. manufacturing plants) in geographically strategic regions, or via limited exclusivity industrial partnerships in the shape of joint ventures.
METabolic EXplorer, based in Clermont-Ferrand, France, is listed on Euronext Paris (Euronext C, METEX) and is a component of the CAC Small index.
Get free financial information on METabolic EXplorer by registering with www.metabolic-explorer.com or www.actus-finance.com.
METabolic Explorer contacts
Media and shareholder contacts
ATTITUDE Corporate Eric de Lambert E-mail: [email protected] Tel.: +33 (0)1 4970 4341 / +33 (0)6 2529 0658
Investor and analyst contacts
Actus Finance Jérôme Fabreguettes-Leib E-mail: [email protected] Tel.: +33 (0)1 7735 0436
This press release includes forward-looking information that is subject to a number of risks and uncertainties. The potential development of the company could be substantially different from that anticipated in this release because of the various risk factors described in the company's Listing Prospectus.